Your Search Returned 500 tagged news reports
The company said that Phase III clinical trials in type 1 and type 2 diabetes will commence soon. Merck senior vice president of Diabetes, Global Human Health Matt Strasburger said the company seeks to collaborate with Samsung Bioepis on this insulin
With diabetes, cardiovascular disease and neurological disorders reaching epidemic proportions, natural remedies that combat these health concerns are in high demand. Alpha lipoic acid (ALA) can help with these pressing issues and more. This
If I needed to have these shots every day for the rest of my life, the only way I'd survive was to do it myself." -- Supreme Court Justice Sonia Sotomayor, in "My Beloved World" Supreme Court Justice Sonia Sotomayor, in a public conversation with
Firstborns may be at higher risk for heart disease and diabetes than their later-born counterparts, new findings suggest. In a small study from New Zealand, researchers looked at 50 overweight men ages 40 to 50, and compared the body mass indexes (
Two Oregon teens were rescued by an off-duty officer after suffering seizures from taking an LSD-like drug new to many parts of the country, police said. The off-duty deputy came upon the two girls, one of whom was actively seizing on the side of a
February 3, 2014 3:00 a.m...Brian Otis gingerly holds what looks like a typical contact lens on his index finger...Sandwiched in this lens are two twinkling glitter-specks loaded with tens of thousands of miniaturized transistors.
Jesper Brandgaard, Chief Financial Officer of Denmark's Novo Nordisk, speaks at the Reuters Health Summit in New York, November 15, 2007. Novo Nordisk, the world's largest insulin producer, raised its 2014 outlook by less than investors had hoped for
After three years of seeing major drugs like Zyprexa for schizophrenia lose patent protection and wipe away billions of dollars in revenue, Eli Lilly and Co Chief Executive Officer John Lechleiter wants to change the game plan.
A number of proof of concept projects are underway, last September Medtronic's MiniMed 530G device was approved by the FDA , and now it seems that there is a new technology entering the fray from the UK. Joan Taylor, a professor of pharmacy at De
Louisiana officials didn't present enough evidence to show J&J violated the state's healthcare-assistance laws with an advertising campaign touting Risperdal's performance and safety, the state's Supreme Court ruled. The Louisiana case was carved out